These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9453083)

  • 21. Association between porphyria cutanea tarda and beta-thalassemia major.
    Barbieri L; Macrì A; Lupia Palmieri G; Aurizi C; Biolcati G
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):36-9. PubMed ID: 19656449
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmunity and HCV infection in porphyria cutanea tarda: a controlled study.
    Stölzel U; Schuppan D; Tillmann HL; Manns MP; Tannapfel A; Doss MO; Zimmer T; Köstler E
    Cell Mol Biol (Noisy-le-grand); 2002 Feb; 48(1):43-7. PubMed ID: 11929046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Porphyria cutanea tarda associated with lymphoma.
    Maughan WZ; Muller SA; Perry HO
    Acta Derm Venereol; 1979; 59(1):55-8. PubMed ID: 84468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of association between porphyria cutanea tarda and alpha 1-antitrypsin deficiency.
    Fargion S; Sergi C; Bissoli F; Fracanzani AL; Suigo E; Carazzone A; Roberto C; Cappellini MD; Fiorelli G
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):387-91. PubMed ID: 8781910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sclerodermatous changes in porphyria cutanea tarda: six cases].
    Khayat R; Dupuy A; Pansé I; Bagot M; Cordoliani F
    Ann Dermatol Venereol; 2013 Oct; 140(10):589-97. PubMed ID: 24090888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Case ∣ A blistering problem in a hemodialysis patient. The Diagnosis | Porphyria cutanea tarda.
    Talmaci L; Davenport A; Burns A
    Kidney Int; 2010 Dec; 78(11):1195-6. PubMed ID: 21076458
    [No Abstract]   [Full Text] [Related]  

  • 28. Symptomatic porphyria secondary to hepatocellular carcinoma.
    Ochiai T; Morishima T; Kondo M
    Br J Dermatol; 1997 Jan; 136(1):129-31. PubMed ID: 9039312
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Familial and sporadic porphyria cutanea tarda: clinical, biochemical and genetic features with emphasis on iron status.
    Bygum A; Christiansen L; Petersen NE; Hørder M; Thomsen K; Brandrup F
    Acta Derm Venereol; 2003; 83(2):115-20. PubMed ID: 12735639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The C282Y mutation in the haemochromatosis gene (HFE) and hepatitis C virus infection are independent cofactors for porphyria cutanea tarda in Australian patients.
    Stuart KA; Busfield F; Jazwinska EC; Gibson P; Butterworth LA; Cooksley WG; Powell LW; Crawford DH
    J Hepatol; 1998 Mar; 28(3):404-9. PubMed ID: 9551677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A mutation (G281E) of the human uroporphyrinogen decarboxylase gene causes both hepatoerythropoietic porphyria and overt familial porphyria cutanea tarda: biochemical and genetic studies on Spanish patients.
    Roberts AG; Elder GH; De Salamanca RE; Herrero C; Lecha M; Mascaro JM
    J Invest Dermatol; 1995 Apr; 104(4):500-2. PubMed ID: 7706766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda.
    Chan OT; Tsai N; Wong RL; Izumi AK
    Cutis; 2006 Dec; 78(6):397-400. PubMed ID: 17243426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A case of porphyria cutanea tarda in association with idiopathic myelofibrosis and CREST syndrome.
    Lee SC; Yun SJ; Lee JB; Lee SS; Won YH
    Br J Dermatol; 2001 Jan; 144(1):182-5. PubMed ID: 11167703
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of hepatitis C virus type 1b in Italian patients with Porphyria cutanea tarda.
    Sampietro M; Fracanzani AL; Corbetta N; Amato M; Mattioli M; Molteni V; Fiorelli G; Fargion S
    Ital J Gastroenterol Hepatol; 1997 Dec; 29(6):543-7. PubMed ID: 9513830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Porphyria cutanea tarda and antibodies to hepatitis C virus.
    Lacour JP; Bodokh I; Castanet J; Bekri S; Ortonne JP
    Br J Dermatol; 1993 Feb; 128(2):121-3. PubMed ID: 7681315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Porphyria cutanea tarda.
    Bleasel NR; Varigos GA
    Australas J Dermatol; 2000 Nov; 41(4):197-206; quiz 207-8. PubMed ID: 11105361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Porphyria cutanea tarda. Don't forget to look at the urine.
    Rich MW
    Postgrad Med; 1999 Apr; 105(4):208-10, 213-4. PubMed ID: 10223097
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Porphyria cutanea tarda affecting lower lip.
    Martínez A; Morales R; Brethauer U; Jiménez M; Alarcón R
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2000 Dec; 90(6):705-8. PubMed ID: 11113814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of porphyria cutanea tarda of end-stage renal disease with erythropoietin.
    Sarkell B; Patterson JW
    J Am Acad Dermatol; 1993 Sep; 29(3):499-500. PubMed ID: 8102386
    [No Abstract]   [Full Text] [Related]  

  • 40. Ineffective interferon treatment of chronic hepatitis C-associated porphyria cutanea tarda, but with a transient decrease in HCV RNA levels.
    Furuta M; Kaito M; Gabazza E; Fujita N; Ishida S; Tamaki S; Ikeda R; Wakisawa S; Hayashi H; Watanabe S; Adachi Y
    J Gastroenterol; 2000; 35(1):60-2. PubMed ID: 10632544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.